# OnCo record preopanc-3 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/preopanc-3/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "preopanc-3", "NCT04927780" ;
  schema:name "PREOPANC-3"@en ;
  schema:alternateName "PREOPANC 3"@en ;
  schema:description "PREOPANC-3 is the European twin of Alliance A021806: the same modified FOLFIRINOX given either around surgery or only afterwards for operable pancreatic cancer. Recruitment of 378 patients has closed and the first results are expected after the January 2027 primary completion date."@en ;
  schema:url <https://onco.cc/trials/preopanc-3/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04927780>, <https://doi.org/10.1186/s12885-023-11141-5> ;
  onco:status "active" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/resectable-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/folfirinox/> ;
  onco:institutions <https://onco.cc/institutions/erasmus-mc/> ;
  onco:terms <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/pancreatic-trials-open-today/> ;
  onco:trials <https://onco.cc/trials/alliance-a021806/>, <https://onco.cc/trials/preopanc/>, <https://onco.cc/trials/preopanc-2/> .